← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 1, 2008Last known activity
Mar 3, 2022
Timeline
1940s
- Jun 7, 1946
Nihon Pharmaceutical Co., Ltd— Founded
Drugs by trial phase (5 distinct, 18 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
- Adenoma
- Disease
- Guillain-Barre Syndrome
- Intestinal Diseases
- Neuritis
- Neuromyelitis Optica
- Pemphigoid, Bullous
- Peripheral Nervous System Diseases
- Polyneuropathies
- Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
- Stevens-Johnson Syndrome
- Stomach Diseases
- Stomach Neoplasms
- Syndrome
- Thrombosis
- Venous Thrombosis
Recent trials (21)
- NCT05177939Lead sponsorPhase 3Mar 3, 2022
- NCT05177939Study chairPhase 3Mar 3, 2022
- NCT04097574Study chairPhase 2Aug 26, 2019
- NCT04097574Lead sponsorPhase 2Aug 26, 2019
- NCT03794310Study chairPhase 3Dec 19, 2018
- NCT03794310Lead sponsorPhase 3Dec 19, 2018
- NCT03263910Lead sponsorPhase 3Aug 21, 2017
- NCT02221271Lead sponsorPhase 3Oct 1, 2014
- NCT02265939Lead sponsorPhase 2Oct 1, 2014
- NCT02250391Lead sponsorPhase 3Sep 1, 2014
- NCT01845584Lead sponsorPhase 2May 1, 2013
- NCT01824251Lead sponsorPhase 3Apr 1, 2013
- NCT01827072Lead sponsorPhase 3Apr 1, 2013
- NCT01696500Lead sponsorPhase 3Oct 1, 2012
- NCT01411189Lead sponsorPhase 3Sep 1, 2011
Details
- Founded
- Tokyo, JP Jun 7, 1946
- Last known activity
- Mar 3, 2022